Yayın: Synthesis and biological evaluation of novel 1,3,<scp>4‐oxadiazole</scp> derivatives as anticancer agents and potential <scp>EGFR</scp> inhibitors
| dc.contributor.author | OSMANİYE, DERYA | |
| dc.contributor.author | Özkay, Yusuf | |
| dc.contributor.author | SAĞLIK ÖZKAN, BEGÜM NURPELİN | |
| dc.contributor.author | LEVENT, SERKAN | |
| dc.contributor.author | KAPLANCIKLI, ZAFER ASIM | |
| dc.contributor.author | Zafer Asım Kaplancıklı | |
| dc.contributor.orcid | 0000-0002-0499-436X | |
| dc.contributor.orcid | 0000-0003-2026-2924 | |
| dc.contributor.orcid | 0000-0002-0151-6266 | |
| dc.contributor.orcid | 0000-0003-3692-163X | |
| dc.contributor.orcid | 0000-0001-8815-153X | |
| dc.contributor.orcid | 0000-0003-2252-0923 | |
| dc.date.accessioned | 2025-11-13T09:48:28Z | |
| dc.date.issued | 2021-11-01 | |
| dc.identifier.doi | https://doi.org/10.1002/jhet.4398 | |
| dc.identifier.endpage | 532 | |
| dc.identifier.issn | 0022-152X | |
| dc.identifier.issue | 3 | |
| dc.identifier.openalex | W3210553611 | |
| dc.identifier.startpage | 518 | |
| dc.identifier.uri | https://hdl.handle.net/11421/2254 | |
| dc.identifier.uri | https://doi.org/10.1002/jhet.4398 | |
| dc.identifier.volume | 59 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Heterocyclic Chemistry | |
| dc.rights | restrictedAccess | |
| dc.subject | Chemistry | |
| dc.subject | Stereochemistry | |
| dc.subject | Docking (animal) | |
| dc.subject | Epidermal growth factor receptor | |
| dc.subject | MTT assay | |
| dc.subject | Cytotoxicity | |
| dc.subject | EGFR inhibitors | |
| dc.subject | Cell culture | |
| dc.subject | A549 cell | |
| dc.subject | Oxadiazole | |
| dc.subject | Tyrosine kinase | |
| dc.subject | Cell growth | |
| dc.subject | Cytotoxic T cell | |
| dc.subject | In vitro | |
| dc.subject | Biochemistry | |
| dc.subject | Receptor | |
| dc.subject | Organic chemistry | |
| dc.subject.sdg | 3 | |
| dc.title | Synthesis and biological evaluation of novel 1,3,<scp>4‐oxadiazole</scp> derivatives as anticancer agents and potential <scp>EGFR</scp> inhibitors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5017640266 | |
| local.authorid.openalex | A5030511747 | |
| local.authorid.openalex | A5074136342 | |
| local.authorid.openalex | A5075534569 | |
| local.authorid.openalex | A5060247565 |
